{
    "eid": "2-s2.0-85148607813",
    "title": "Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy",
    "cover-date": "2023-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "allergen immunotherapy",
        "allergic rhinitis",
        "HDM",
        "SCIT",
        "SLIT tablets"
    ],
    "authors": [
        "Ploykarn Kiatiwat",
        "Atik Sangasapaviliya",
        "Panitan Pradubpongsa",
        "Sasipa Sangkanjanavanich",
        "Chirawat Chiewchalermsri",
        "Alain Jacquet",
        "Nattapol Jaisupa",
        "Sarawut Jindarat",
        "Tadech Boonpiyathad",
        "Wat Mitthamsiri"
    ],
    "citedby-count": 1,
    "ref-count": 10,
    "ref-list": [
        "Sublingual or subcutaneous immunotherapy for allergic rhinitis?",
        "Cost utility analysis of the SQ((R)) HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting",
        "Allergic rhinitis: what do we know about allergen-specific immunotherapy?",
        "A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes",
        "COVID-19 pandemic and allergen immunotherapy-an EAACI survey",
        "Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI position paper",
        "T regulatory cells from atopic asthmatic individuals show a Th2-like phenotype",
        "Increased circulating CRTH2(+) Tregs are associated with asthma control and exacerbation",
        "The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases",
        "Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60006964",
            "affilname": "Phramongkutklao College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006964",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60033133",
            "affilname": "Bangkok Metropolitan Administration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033133",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60000316",
            "affilname": "Srinakharinwirot University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000316",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Phramongkutklao Hospital and Phramongkutklao College of Medicine foundation"
    ]
}